Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Colulintide by Eli Lilly and Co for Obesity: Likelihood of Approval
Colulintide is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData,...